Contact this trialFirst, we need to learn more about you.
GLP-1 Receptor Agonist
Oral Semaglutide for Metabolic Diseases
Recruiting3 awardsPhase 4
Boston, Massachusetts
This trial aims to understand how genetic differences affect the way the body responds to a medication called oral semaglutide, commonly used to treat diabetes and obesity. Participants will have their blood tested before and
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.